OVER ONE HUNDRED AND FIFTY YEARS AGO, a scientist by the name of Virchow (106) recognized that there was an association between hemoglobin breakdown and biliverdin. It was not until 1926, however, that this association was more formally established by Mann et al. (56) . But certainly the manifestations of this metabolic process were recognized hundreds if not thousands of years earlier because the catabolism of heme is the only biological process in humans that is colorimetric. After receiving a blow to the skin, primitive man would have observed shortly thereafter a bruise that was black or purple. These are colors of heme, released into the dermis from pulverized erythrocytes. The black hue (heme) gradually transformed to green, the color of biliverdin, and finally to yellow, the color of bilirubin, the concluding product of this elegant enzymatic reaction. To this day, investigators have been intrigued by the role of this end product as well as that of ferritin, the iron storage protein in the cell induced by the release of free iron and carbon monoxide (CO) and released in equimolar concentrations as heme anabolism transpires (see Fig. 1 ).
HEME OXYGENASE
Heme oxygenase (HO) was originally identified in 1968 and 1969 by Tenhunen et al. (100, 101) in seminal papers where they characterized the enzyme HO as well as its cellular localization. HO catalyzes the first and rate-limiting step in the degradation of heme. Via oxidation, HO cleaves the ␣-meso carbon bridge of b-type heme molecules to yield equimolar quantities of biliverdin IXa, CO, and free iron. Biliverdin is subsequently converted to bilirubin via the action of biliverdin reductase, and free iron is promptly sequestered into ferritin. To date, three isoforms (HO-1, HO-2, and HO-3) that catalyze this reaction have been identified (1, 54, 60, 61) . HO-1 is a 32-kDa protein that is induc-ible by numerous stimuli (Table 1 ) and is the principal focus of this review. HO-2 is, for the most part, a constitutively synthesized 36-kDa protein existing primarily in the brain and testes. HO-3, a recently cloned gene product 33 kDa in size, also catalyzes heme degradation but much less than HO-2. Under physiological conditions, HO activity is highest in the spleen where senescent erythrocytes are sequestered and destroyed, but its activity has also been observed in all systemic organs.
Although heme is the typical HO-1 inducer, studies by Keyse and Tyrrell (41), Maeshima et al. (53), and Vile and Tyrrell (105) demonstrated that HO enzyme activity could also be stimulated by a variety of nonheme products including ultraviolet irradiation, endotoxin, heavy metals, and oxidants such as hydrogen peroxide. One common feature of these inducers is their capacity to generate reactive oxygen species. Thus these studies not only demonstrated that HO-1 can be induced by agents causing oxidative stress but also supported the speculation that HO-1 can function as a cytoprotective molecule against oxidative stress. Indeed, ample evidence currently supports the notion that HO-1 serves to provide potent cytoprotective effects in many in vitro and in vivo models of oxidantinduced cellular and tissue injury. Table 1 illustrates a list of the agents that when administered to cells or animals result in an increase in HO-1 expression. The list represents a wide variety of nonheme inducers of this enzyme, the scope of such indexes giving rise to a fundamental question as to the functional role(s) of the increased levels of this ubiquitous enzyme.
INDUCTION OF HO-1 EXPRESSION
Although the function of this enzyme is still incompletely understood, accumulating evidence to date strongly suggests that the endogenous induction of HO-1 provides potent cytoprotective effects in various in vitro and in vivo models of cellular and tissue injury (34, 75, 93) . This evolving paradigm is further supported by observations made in the HO-1-deficient [HO-1(Ϫ/Ϫ)] mouse and human. Poss and Tonegawa (80, 81) in 1997 generated HO-1(Ϫ/Ϫ) mice by targeted deletion of the mouse HO-1 gene. The majority of these HO-1(Ϫ/Ϫ) mice do not survive to term, and the mice that do survive to adulthood are abnormal and die within one year of birth (80, 81) . These adult mice exhibit growth retardation and normochromic, microcytic anemia. Kidneys and livers from these mice show evidence of iron deposition, and as these HO-1(Ϫ/Ϫ) mice age, they also demonstrate an increased presence of chronic inflammation characterized by hepatosplenomegaly, leukocytosis, glomerulonephritis, and hepatic periportal inflammation. These authors also reported that cells obtained from these mice are more susceptible to oxidative stress induced by endotoxin. A recent report (111) demonstrating the first identified case of a HO-1-deficient human patient lends additional support to the evolving paradigm that HO-1 serves to provide cytoprotection against oxidative stress. This patient exhibited similar phenotypic alterations as those observed in the HO-1(Ϫ/Ϫ) mice, including growth retardation, anemia, leukocytosis, and increased sensitivity to oxidant stress.
The critical importance of HO is also demonstrated by recent reports (47, 65) that HO expression is conserved evolutionarily. It has been detected in prokaryotic bacteria as well as in plants and fungi. This conservation suggests that HO may play a role in diverse species as a modulator of cellular homeostasis, serving not only to degrade heme but also, via one or more of its catabolic by-products, to regulate a variety of critical cellular processes. For example, in plants, it is believed that HO possesses dual functions, one that generates tetrapyrroles and another that recycles heme and chlorophylls, both being important after damage to the photoreactive centers (65) . In most bacteria, iron is required for survival and is particularly essential for pathogens to cause disease. To circumvent the low concentration of free extracellular iron, pathogenic bacteria have developed sophisticated mechanisms by which to acquire iron from iron-containing proteins found in their hosts. One such mechanism exploits a bacterial heme degradation enzyme similar to HO (47). In contrast to the mammalian HO, the primary purpose of which is to maintain iron homeostasis, the purpose of the bacterial HO is to release iron from heme so that the iron may be immediately utilized. Such conservation among species that express and regulate this enzyme gives credence to the belief that HO is critically important in maintaining cellular homeostasis. Table 2 illustrates a list of disease states that have been associated with the increased expression of HO-1. Most recently, Schipper et al. (87) have described the use of HO-1 expression as an indicator of cellular stress and injury. Plasma and cerebrospinal fluid samples collected from Alzheimer's patients were analyzed by ELISA for HO-1 induction and found to be elevated in the blood of pathologically confirmed Alzheimer's patients (87) . Although oxidative stress has been well described as a potent inducer of HO-1, this study presented the first reported evidence that suggested that HO-1 expression can be used as a diagnostic tool to evaluate patients with this disease. Indeed, these authors proposed that HO-1 levels can be used as a biological marker to diagnose and monitor those with this disease. Investigators (37, 77) have reported using the detection of CO as a measurable marker in the exhaled breath of patients as an index of oxidative stress and inflammation. Bilirubin has also been used as a marker of liver injury and neonatal jaundice for years and continues to provide valuable information as a biological marker.
MECHANISM(S) OF CYTOPROTECTION BY HO-1
The increased expression of HO-1 levels in a variety of pathological states begs the question as to the functional role for this heme catalyzing enzyme. Keyse and Tyrrell (40, 41), followed shortly thereafter by Nath et al. (66) , demonstrated in critical studies that HO-1 provided cytoprotection against oxidative stress, particularly if HO-1 was induced before the stress. These two studies prompted increased investigations of this enzyme in disorders that do not relate to heme catabolism. Ample evidence now strongly suggests that HO-1 can function as a critical cytoprotective molecule. The mechanism(s) by which HO-1 can mediate these cytoprotective functions is not clear. However, the three major catalytic by-products, CO, ferritin, and bilirubin may represent potential targets.
CO. CO is one of the most commonly encountered toxic agents because it interferes with O 2 delivery to cells and tissues. It is, after carbon dioxide (CO 2 ), the most abundant atmospheric pollutant, emanating slowly from natural sources such as volcanoes and forest fires but more rapidly and abundantly as a by-product of industrial and technological activity (e.g., the combustion engine). In 1857, Claude Bernard described the affinity of CO for hemoglobin, thus initiating research that eventuated in an essentially universal scientific tenet assigning CO to the category of poisons and toxins that later came to include arsenic, nicotine, and opium. Before this time, it was common practice in Europe to pacify infants by holding them over a fire where CO-induced cerebral anoxia could exert its sedating and soothing effects. Since Bernard's discovery of the CO-hemoglobin affinity, the particulars of that association as well as its lethal consequences have been well delineated. In 1927, Nicloux discovered a baseline carboxyhemoglobin level in dogs and concluded that CO originated in the body itself. A year earlier, in 1926, Campbell was already calling the gas a "poison," a label that over the years has become as essential and self-evident a feature of its conceptualization as its atomic structure. In 1972, Weinstock and Niki observed, with a palpable trace of ironic understatement: "Carbon monoxide may be the basis of energy metabolism in some extraterrestrial civilization. Certainly endogenous CO metabolism is of less importance to life on earth."
The dangers of CO have been well defined. By binding avidly to hemoglobin, it replaces O 2 , induces general hypoxia, increases the stability of oxyhemoglobin by shifting the dissociation curve to the left, and impedes O 2 delivery to the tissues. Furthermore, dissociation of CO 2 is impaired, thus producing an increase in blood CO 2 levels and removing the reflex stimulus to the respiratory centers in the brain. In addition, because no change occurs in the dissolved O 2 levels in the blood, the carotid sinus detects no disparity because it responds only to partial pressure; so it likewise sends no signals to the respiratory centers of the brain that would otherwise force the individual to breathe more often to increase the blood O 2 levels.
Because of its strong affinity for hemoglobin, the primary toxic effect of CO is hypoxia or anoxia. Increases in combustion through the use of fossil fuels over the past century and consequent increases in CO levels in the atmosphere have heightened public awareness of exposure to this gas and its noxious potential. The Environmental Protection Agency via various media instills in the public mind a need to avoid this gas, recommending elaborate protective alarms and detectors and publishing allowable expo- sure limits. The number of studies investigating these issues, particularly those relating to the toxic effects of CO, is immense. In 1970, the New York Academy of Sciences held a symposium on the physiological effects of exposure to this gas to address these issues. Toxicologists have outlined quite precisely the pathophysiological effects resulting from exposure to CO as shown in Table 3 . Among all the negative connotations associated with this gaseous molecule, evidence accumulating in the past five years is beginning to shed new light on this historically categorized poison. At high concentrations, CO is unquestionably lethal. But recent studies (55, 64, 104) consistently support the emerging idea that CO at low concentrations exerts distinctly different effects on physiological and cellular functions, this revelation motivating the need to reevaluate its role.
Certainly, contemporary neurobiologists and vascular biologists believe it is important in their systems. The pioneering work of Snyder et al. (92) and Morita and Kourembanas (62) have clearly shown that CO generated from HO, the primary if not exclusive source of CO generation in the body, can regulate vasomotor tone as well as neurotransmission. These findings provided the first evidence that this simple gaseous molecule could impart critical biological functions akin to NO. Just as NO functions as a signaling molecule, so does CO play an important role in regulating vasomotor tone by promoting vasorelaxation (84) . Furthermore, Yet et al. (114) have also observed that HO-1(Ϫ/Ϫ) mice exhibited a maladaptive response to chronic hypoxia, with the development of right ventricular infarcts and organized mural thrombi resulting in pulmonary hypertension (114) . This regulatory function may indeed account for the anti-inflammatory effects of HO-1 expression in endothelial and smooth muscle cells because vasorelaxation may allow maintenance of blood flow at sites of inflammation, such relaxation countering those effects of coagulation and thrombosis that can lead to anoxia and tissue necrosis.
These effects of CO are mediated through the activation of guanylyl cyclase on the binding of CO to the heme moiety of this enzyme and subsequent cGMP generation (12) . But the vasodilator function of CO is thought to be 50-100 times less potent than that of NO based on the capacity of both molecules to activate guanylyl cyclase, the common mediator of these molecules in modulating smooth muscle cell relaxation and vasodilatation (113) . However, the relative inefficiency of CO in binding guanylyl cyclase may be largely neutralized because although NO is extremely reactive and labile, CO is chemically very stable. Unlike NO, CO reacts exclusively with heme and thus can accumulate in the cell to levels that are presumably much higher then those of NO. CO may also possess antiinflammatory effects such as the capacity to inhibit platelet activation or aggregation through activation of guanylyl cyclase and subsequent generation of cGMP. Furthermore, CO when administered exogenously to rats or mice at very low concentrations can provide protection in models of lung injury (72, 73) .
Recent studies also suggest that changes in CO measurements in exhaled breath are indicative of increased HO-1 activity and cellular stress and therefore can be correlated with the severity of some disease processes. For example, Paredi et al. (77) and Yamara et al. (113) have shown increased CO in the breath of patients with disease processes as diverse as asthma and diabetes (77, 113) .
Biliverdin and bilirubin. Bilirubin is the most abundant endogenous antioxidant in mammalian tissues, accounting for the majority of the antioxidant activity of human serum (32). Bilirubin has been shown to be a potent antioxidant in the brain, acting to scavenge peroxyl radicals as efficiently as ␣-tocopherol or vitamin E (94). Bilirubin is best known, however, as a potentially toxic agent that accumulates in the serum of neonates, causing jaundice. In high concentrations, it deposits in selected brain regions to elicit neurotoxicity associated with kinicterus (33). On the other hand, neonatal jaundice could also have a protective effect for the infant arriving for the first time into an unsterile environment. In a recent report, Vachharajani et al. (103) observed that administration of biliverdin to rats modulates lipopolysaccharide-induced Pand E-selectin expression in the vascular system, providing evidence that bilirubin is able to modulate this inflammatory response regardless of the influences of HO-1, CO, and/or ferritin (103) .
Biliverdin administration to rodents has also recently been shown to provide protection in a rat model of ischemic heart injury (103). Another report by Dore et al. (25) further demonstrated that bilirubin manifests cytoprotective properties in a model of hydrogen peroxide-induced oxidative injury to neurons as does a report by Clark et al. (18) who showed that bilirubin administration in a model of ischemic heart injury is protective, suggesting that this end product of heme catabolism is more than a waste product that simply requires elimination.
Ferritin. The release of free iron (its two free electrons capable of generating the vicious hydroxyl radical) through Fenton chemistry with the superoxide radical is rapidly sequestered into the iron storage protein ferritin (Fig. 1) . Such sequestration can itself lower the prooxidant state of the cell by removing the free iron (8) . Vile and Tyrrell (105) showed that ferritin levels increase in the presence of oxidative stress such as ultraviolet irradiation. This HO-1-dependent re- (10) demonstrated that overexpression of HO-1 also upregulates and interacts with an iron ATPase present in the endoplasmic reticulum. This iron pump is thought to limit intracellular iron content once HO-1 activity is upregulated. This limiting effect may be particularly important when cells are exposed to high levels of heme that increase HO-1 activity, thus generating high levels of intracellular free iron. The ability of cells expressing HO-1 to decrease iron content has recently been suggested to account in large measure for the antiapoptotic effects of HO-1 (15, 78, 89) . Other molecules that chelate intracellular free iron are also thought to prevent apoptosis, suggesting that upregulation of ferritin by HO-1 may have a similar effect in preventing apoptosis.
HO-1 EXPRESSION IN THE LUNG
Like many of the organ systems affected by the pathologies listed in Table 2 , the lung is no exception with regard to the induction of HO-1. The induction of HO-1 has been demonstrated in many models of lung injury including hyperoxia, endotoxemia, bleomycin, asthma, acute complement-dependent lung inflammation, and heavy metals. The physiological function of this robust HO-1 induction primarily points to the cytoprotective effects of HO-1. In an in vitro model of oxidative stress with stably transfected HO-1-overexpressing pulmonary epithelial cells, Lee et al. (48) demonstrated that these cells exhibited increased resistance to hyperoxic cell injury. Similar protective effects of HO-1 were also observed by Suttner et al. (98) in rat fetal lung cells exposed to hyperoxia. In studies by Petrache et al. (78) 21) demonstrated that HO-2-null mice were sensitized to hyperoxia-induced oxidative injury and mortality despite increased HO-1 expression. Furthermore, Suttner and Dennery (97) have also observed that moderate overexpression of HO-1 in fibroblasts is protective against oxidative injury, whereas high levels of HO-1 expression can be associated with significant O 2 cytotoxicity. These authors speculate that the accumulation of reactive iron released from the catalysis of heme may impart cellular cytotoxicity.
Rodent models of septic shock and hyperoxic lung injury represent two clinically relevant research models in the study of lung injury. Each provides pertinent information that can lead to a better understanding of clinical disease because although they diverge in terms of their relative cytotoxic etiologies and tissue injury dynamics, they are closely intertwined at the intracellular level. Both generate enormous amounts of reactive oxygen species that represent the fundamental underlying mechanisms responsible for tissue injury. Otterbein and colleagues (71, 72, 74) have demonstrated that HO-1 induction correlated with cytoprotection against oxidative stress in vivo. Using hyperoxia as a model of acute respiratory distress syndrome in rats, they hypothesized that the exogenous administration of HO-1 by gene transfer would confer protection against oxidant-induced tissue injury. Adenoviral gene transfer of HO-1 (Ad5-HO-1) into the lungs of rats resulted in increased expression of HO-1 and, more importantly, a marked resistance to hyperoxic lung injury (74) . Rats treated with Ad5-HO-1 showed reduced levels of hyperoxia-induced pleural effusion, neutrophil alveolitis, and bronchoalveolar lavage protein leakage. Furthermore, rats treated with Ad5-HO-1 showed increased survivability against hyperoxic stress versus those treated with the vector control virus AdV-␤Gal. These data are supported by Taylor et al. (99) , who demonstrated that intratracheal administration of hemoglobin, a major inducer of HO-1, also provided protection from hyperoxic lung injury. They concluded, however, that the protection was perhaps conferred via ferritin and not directly by HO-1.
In view of the observations that exogenous administration of HO-1 via transgene delivery provided cytoprotection against hyperoxia in rats, Otterbein et al. (75) then examined whether exogenous CO could impart similar cytoprotective effects. Indeed, CO at low concentrations [10-500 parts/million (ppm)], well tolerated both by rodents and cells, provided protective effects against hyperoxia similar to those observed in the transgene studies (104) . Previous work by Stupfel and Bouley (96) had clearly shown that rodents can be exposed to 500 ppm CO continuously for up to 2 yr without deleterious effects on multiple physiological and biochemical parameters. Based on these studies and many others, concentrations chosen for exposures ranged from 50 to 500 ppm. Rats exposed to hyperoxia in the presence of a low concentration of CO (250 ppm) were similarly protected from hyperoxic stress, with reduced markers of injury and increased survivability. These studies strongly suggested that CO exerted its protective effects via anti-inflammatory and/or antiapoptotic effects.
These results provided the direction for the next series of studies in which an attempt was made to delineate the potential mechanism(s) by which CO provided cytoprotection against oxidative stress. Otterbein et al. (73) hypothesized that CO mediated the anti-inflammatory effects, thus providing the potent cytoprotection. This hypothesis was tested in vivo in mice and in vitro in RAW 264.7 macrophage cells. CO inhibited the lipopolysaccharide-induced proinflammatory cytokines TNF-␣, interleukin (IL)-1␤, and macrophage inflammatory protein (MIP)-1␣ but augmented the anti-inflammatory cytokine IL-10 expression in vitro. Likewise, inhibition of the proinflammatory cytokine TNF-␣ and augmentation of the cytokine IL-10 were also observed in vivo. Because of the evidence that cGMP serves as an important mediator involved in CO and NO signaling in other model systems, in particular the central nervous system and vascular cells, Otterbein et al. (73) examined whether CO mediated the anti-inflammatory effects via the guanylyl cyclase/cGMP pathway. Interestingly, cGMP was not involved, but rather the observed anti-inflammatory effects of CO were dependent on the mitogen-activated protein kinase kinase (MKK-3)/p38 mitogen-activated protein kinase pathway. Further studies (73) to corroborate the involvement of p38 in the mechanism producing the CO effects were performed in mice deficient in MKK-3, the major upstream kinase activator of p38. Endotoxin administration to MKK-3-deficient mice exposed to air resulted in the inhibition in TNF-␣ as expected but with no additional inhibition when exposed to CO. Further examination revealed that IL-10 levels were not augmented in the presence of CO in these mice as observed in the wild-type littermates. These findings confirmed the involvement of the MKK-3/p38 pathway in the effects observed with CO.
CONCLUSIONS
Although the mechanism(s) mediating HO-1-induced cytoprotection remains elusive, recent data point to one of the by-products of heme catabolism [CO, Fe 2ϩ (ferritin), or bilirubin] as potential mediators of HO-1 cytoprotection. Even though each product has been shown to be protective, it could indeed be a combination of the three by-products that act adaptively to protect the cell and tissue from further insult. Although progress has been made in our understanding of the function of HO-1 after oxidative stress, there is much work to be done to delineate more clearly the role of HO-1 induction in lung biology and pathology. The players (CO, ferritin, and bilirubin) have been identified, but the destinies and interactions among these characters remain elusive; gas molecules, metal ions, and organic antioxidants, all intermingling within the cellular milieu affecting biological processes, all categorically toxic, all possess some manner of physiological function in the vastly complex cellular and molecular environment. At some point, investigators may fully understand the interplay of these characters and, most importantly, the mechanism by which this remarkable enzyme invokes the colors of defense against a plethora of insults. And hopefully, in the near future, this knowledge will help in the discovery of novel therapeutic modalities with which to treat acute lung injury as well as a multitude of other disease states. 
